Avidity Biosciences, Inc.
General ticker "RNA" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $232.5M (TTM average)
Avidity Biosciences, Inc. does not follow the US Stock Market performance with the rate: -11.3%.
Estimated limits based on current volatility of 1.6%: low 11.91$, high 12.31$
Factors to consider:
- Total employees count: 391 (+54.5%) as of 2024
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Pending novartis transaction completion, Acquisition/divestiture risks, Litigation risks, Operational and conduct risks, Financing unavailable
Short-term RNA quotes
Long-term RNA plot
Financial data
| YTD | 2025-12-31 |
|---|---|
| Operating Revenue | $18.75MM |
| Operating Expenses | $764.70MM |
| Operating Income | $-745.94MM |
| Non-Operating Income | $61.31MM |
| R&D Expense | $559.16MM |
| Income(Loss) | $-684.63MM |
| Net Income(Loss)* | $-76.68MM |
| Stockholders Equity | $1,688.60MM |
| Assets | $1,958.05MM |
| Operating Cash Flow | $-650.44MM |
| Capital expenditure | $1.45MM |
| Investing Cash Flow | $-38.03MM |
| Financing Cash Flow | $850.99MM |
| Earnings Per Share** | $-4.48 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.